Vident Advisory’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$327K Buy
+10,044
New +$327K ﹤0.01% 1266
2024
Q4
Sell
-2,172
Closed -$248K 1524
2024
Q3
$248K Buy
+2,172
New +$248K 0.01% 1202